CAR T-cell therapy for glioblastoma: recent clinical advances and future challengesStephen Bagley, Donald M. O’Rourke|Neuro-Oncology|2018Cited by 314
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent GlioblastomaJoseph S. Durgin, Donald M. O’Rourke|Frontiers in Oncology|2021Cited by 73
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic IsoformsRadhika Thokala, Donald M. O’Rourke|Frontiers in Oncology|2021Cited by 37